HDAC9 and cancer: Currently, epigenetic therapy for malignant neoplasms is being evaluated in a number of malignancies using DNA methylation and HDAC inhibitors either alone or in combination with the aim of reactivating the expression of aberrantly silenced tumor suppressor genes [25,27-29].